Macroscopic lesions of maternal and fetal vascular malperfusion in stillborn placentas: Diagnosis in the absence of microscopic histopathological examination.

Fetal vascular malperfusion Macroscopic evaluation Maternal vascular malperfusion Stillbirth

Journal

Placenta
ISSN: 1532-3102
Titre abrégé: Placenta
Pays: Netherlands
ID NLM: 8006349

Informations de publication

Date de publication:
07 09 2023
Historique:
received: 11 04 2023
revised: 06 06 2023
accepted: 27 07 2023
pmc-release: 07 09 2024
medline: 15 9 2023
pubmed: 4 8 2023
entrez: 3 8 2023
Statut: ppublish

Résumé

Lesions of maternal vascular malperfusion (MVM) and fetal vascular malperfusion (FVM) are common in placentas associated with both stillbirth and live birth. The objective of this study was to identify lesions present more commonly in stillborn placentas and those most indicative of MVM and FVM without microscopic pathologic evaluation. Data were derived from the Stillbirth Collaborative Research Network. Lesions were identified according to standard protocols published previously and categorized as either MVM or FVM according to the Amsterdam Placental Workshop Group Consensus Statement and macroscopic "umbilical cord at risk" findings. Multivariate logistic regression was used to determine the odds of stillbirth with macroscopic findings of MVM or FVM. 595 stillbirths and 1,305 live births were analyzed. FVM lesions (85.2%) were marginally more common (though not statistically different) in stillbirths compared to MVM lesions (81.3%). Macroscopic findings of both MVM and FVM were more common in stillbirths versus livebirths (p < 0.001). Odds ratios of macroscopic MVM and FVM lesions for stillbirth, adjusted for gestational age at delivery, maternal race (minority), ethnicity (Hispanic), age, and history of hypertension or diabetes, were 1.48 (95% CI 1.30-1.69) and 1.34 (95% CI 1.18-1.53), respectively. Macroscopic features of MVM and FVM are associated with higher odds of stillbirth versus live birth even when controlled for gestational age and maternal factors, which may be a useful clue in determining the pathophysiology of these events. This information is also useful for pathologists when microscopic examination is not available.

Identifiants

pubmed: 37536149
pii: S0143-4004(23)00453-8
doi: 10.1016/j.placenta.2023.07.296
pmc: PMC10530266
mid: NIHMS1923000
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

60-65

Subventions

Organisme : NICHD NIH HHS
ID : U10 HD045953
Pays : United States
Organisme : NICHD NIH HHS
ID : U01 HD045954
Pays : United States
Organisme : NICHD NIH HHS
ID : U10 HD045925
Pays : United States
Organisme : NICHD NIH HHS
ID : U10 HD045952
Pays : United States
Organisme : NICHD NIH HHS
ID : U10 HD045955
Pays : United States
Organisme : NICHD NIH HHS
ID : U10 HD045944
Pays : United States

Informations de copyright

Copyright © 2023 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this article.

Références

Semin Perinatol. 2015 Feb;39(1):2-8
pubmed: 25455619
Am J Perinatol. 1997 Oct;14(9):555-7
pubmed: 9394166
Ultrasound Obstet Gynecol. 2016 Nov;48(5):579-584
pubmed: 27781319
Obstet Gynecol. 2010 Aug;116(2 Pt 1):254-260
pubmed: 20664383
Paediatr Perinat Epidemiol. 2011 Sep;25(5):425-35
pubmed: 21819424
APMIS. 2018 Jul;126(7):561-569
pubmed: 30129125
Eur J Obstet Gynecol Reprod Biol. 2010 Feb;148(2):125-30
pubmed: 19897298
Dev Biol. 2008 Aug 1;320(1):79-91
pubmed: 18550048
Placenta. 2013 Jul;34(7):583-8
pubmed: 23642640
Am J Forensic Med Pathol. 2009 Mar;30(1):64-8
pubmed: 19237859
J Obstet Gynaecol Res. 2017 Aug;43(8):1285-1292
pubmed: 28613009
Am J Obstet Gynecol. 2021 Dec;225(6):660.e1-660.e12
pubmed: 34111407
J Perinat Med. 2018 Apr 25;46(3):323-331
pubmed: 28915123
Placenta. 2016 Jul;43:61-8
pubmed: 27324101
Obstet Gynecol. 2017 Nov;130(5):1112-1120
pubmed: 29016509
PLoS One. 2020 Feb 6;15(2):e0228664
pubmed: 32027702
J Matern Fetal Neonatal Med. 2020 Dec;33(23):4022-4029
pubmed: 30870055
J Perinat Med. 2013 Nov;41(6):701-3
pubmed: 23828421
J Matern Fetal Neonatal Med. 2016 Dec;29(24):4035-6
pubmed: 26866304
Am J Perinatol. 2012 Mar;29(3):187-202
pubmed: 21815127
Singapore Med J. 2009 Dec;50(12):1123-33
pubmed: 20087546
Pediatr Pathol Lab Med. 1996 Nov-Dec;16(6):901-7
pubmed: 9025888
APMIS. 2018 Jul;126(7):621-625
pubmed: 30129128
Arch Pathol Lab Med. 2016 Jul;140(7):698-713
pubmed: 27223167
J Matern Fetal Neonatal Med. 2022 May;35(9):1677-1682
pubmed: 32429723
APMIS. 2018 Jul;126(7):551-560
pubmed: 30129127
Eur J Obstet Gynecol Reprod Biol. 2006 Sep-Oct;128(1-2):15-21
pubmed: 16513243
Am J Perinatol. 2011 Dec;28(10):781-92
pubmed: 21717387

Auteurs

Tess E K Cersonsky (TEK)

Warren Alpert Medical School of Brown University, 222 Richmond St, Providence, RI, 02903, USA. Electronic address: tess.cersonsky@gmail.com.

Robert M Silver (RM)

Department of Obstetrics & Gynecology, University of Utah School of Medicine, 30 N 1900 E, # 2B200 SOM, Salt Lake City, UT, 84132, USA.

George R Saade (GR)

Department of Obstetrics & Gynecology, University of Texas Medical Branch, 1005 Harborside Dr, 3rd Floor, Galveston, TX, 77555, USA.

Donald J Dudley (DJ)

Department of Obstetrics & Gynecology, University of Virginia, 200 Jeanette Lancaster Way, Charlottesville, VA, 22903, USA.

Uma M Reddy (UM)

Department of Obstetrics & Gynecology, Columbia University School of Medicine, 622 West 168th Street, New York, NY, 10032, USA.

Halit Pinar (H)

Warren Alpert Medical School of Brown University, 222 Richmond St, Providence, RI, 02903, USA; Department of Pathology, Women and Infants Hospital of Rhode Island, Warren Alpert Medical School of Brown University, 101 Dudley St, Providence, RI, 02905, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH